JohnJLetterioMD
Pediatric Hematology & Oncology • Cleveland, OHProfessor, Pediatrics, Case Western Reserve University School of Medicine
Dr. Letterio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave Department of Pediatrics-Hematology and Oncology
Cleveland, OH 44106Phone+1 216-844-7700Fax+1 216-844-5431
Education & Training
Case Western Reserve Univ/Univ Hosps Cleveland Med Ctr/Rainbow Babies and Childrens HospitalResidency, Pediatrics, 1987 - 1990
Ohio State University College of MedicineClass of 1987
Certifications & Licensure
OH State Medical License 2007 - 2026
MD State Medical License 1990 - 2008
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- A Core NRF2 Gene Set Defined Through Comprehensive Transcriptomic Analysis Predicts Selective Drug Resistance and Poor Multicancer Prognosis.George Luo, Harshita Kumar, Kristin Aldridge, Stevie Rieger, EunHyang Han
Antioxidants & Redox Signaling. 2024-12-01 - LOCC: a novel visualization and scoring of cutoffs for continuous variables with hepatocellular carcinoma prognosis as an example.George Luo, Toby Chen, John J Letterio
BMC Bioinformatics. 2024-09-27 - 2 citationsTm4sf19 deficiency inhibits osteoclast multinucleation and prevents bone loss.Sujin Park, Jin Sun Heo, Seiya Mizuno, Minwoo Kim, Haein An
Metabolism. 2024-02-01
Abstracts/Posters
- Preclinical Studies and Phase I Trial of Vactosertib in Combination with Pomalidomide in Relapsed Multiple Myeloma: A Corticosteroid-Free Approach By Targeting TGF-_ S...John Letterio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Vactosertib, a TGF-ß Receptor I Kinase/ALK5 Inhibitor, Diminishes Tumor Progression and Bone Disease in a Mouse Model of Multiple Myeloma and Overcomes Resistance to P...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Preclinical Studies and a Phase I Trial of the TGF-β Receptor Inhibitor, Vactosertib (TEW-7197), in Combination with Pomalidomide in Patients with Multiple Myeloma Ref...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
National Experts Map Out Adolescent and Young Adult (AYA) Cancer Research AgendaDecember 5th, 2017
St. Baldrick's Head Shaving for Cancer Research at Rainbow Babies & Children's HospitalMarch 10th, 2017
Colon Cancer in Millennials? Two Cleveland Area Women Warning Others About Rare DiagnosisDecember 27th, 2016- Join now to see all
Grant Support
- Discovery And Evaluation Of Novel Triterpenoid Chemopreventives In A New Colon CANational Cancer Institute2008–2009
- Tgf-Beta1 In Hematopoietic And Immune Cell DifferentiatiDivision Of Basic Sciences - Nci2002–2004
- Tgf-Beta1 In Hematopoietic &Immune Cell DifferentiationDivision Of Basic Sciences - Nci2003
- Tgf-Beta1: Hematopoietic And Immune Cell DifferentiationDivision Of Basic Sciences - Nci2001
- Tgf-Beta1 In Hematopoietic And Immune Cell Differentiation And FunctionDivision Of Basic Sciences - Nci1999–2000
- TGF Beta In Hematopoietic And Immune Cell Differentiation And FunctionDivision Of Basic Sciences - Nci1996–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
